← back to search

Anila Yasmeen

Cornell University · US
Area of research
Virology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include HIV Research and Treatment, Monoclonal and Polyclonal Antibodies Research, HIV/AIDS drug development and treatment, and Immune Cell Function and Interaction.
h-index
30
citations
4,697
works
59
NIH funding
primary concept
email

Recent publications

Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science 2025cited by 35position: middledoi
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
Science Immunology 2024cited by 36position: middledoi
Immunization with germ line–targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques
Science Immunology 2024cited by 20position: middledoi
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
Cell Reports Medicine 2023cited by 50position: middledoi
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
Pathogens and Immunity 2021cited by 132position: middledoi
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Cell Reports 2021cited by 66position: middledoi
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
eLife 2020cited by 186position: middledoi
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
PLoS Pathogens 2020cited by 75position: middledoi
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
Nature Communications 2019cited by 212position: middledoi
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
Immunity 2017cited by 261position: middledoi
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
The Journal of Experimental Medicine 2017cited by 201position: middledoi
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
Cell Reports 2017cited by 176position: middledoi
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate
Biotechnology and Bioengineering 2017cited by 85position: middledoi
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers
Journal of Virology 2017cited by 46position: middledoi
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Nature Microbiology 2016cited by 162position: middledoi
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
Cell 2015cited by 372position: middledoi
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B <i>env</i> Gene
Journal of Virology 2015cited by 255position: middledoi
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens
Proceedings of the National Academy of Sciences 2015cited by 123position: middledoi
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
PLoS Pathogens 2015cited by 103position: middledoi
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
Nature Communications 2015cited by 101position: middledoi
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers
Journal of Virology 2015cited by 82position: middledoi
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
Retrovirology 2014cited by 148position: firstdoi
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
PLoS Pathogens 2013cited by 1,002position: middledoi
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
Proceedings of the National Academy of Sciences 2013cited by 181position: middledoi
Influences on Trimerization and Aggregation of Soluble, Cleaved HIV-1 SOSIP Envelope Glycoprotein
Journal of Virology 2013cited by 89position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Per Johan Klasse · Cornell University16 papers (2013–2021)Andrew B. Ward · Scripps (United States)15 papers (2013–2021)Rogier W. Sanders · Scripps Research Institute15 papers (2013–2021)John P. Moore · Cornell University15 papers (2013–2021)Albert Cupo · Cornell University12 papers (2013–2021)Ian A. Wilson · Raigmore Hospital12 papers (2013–2017)Gabriel Ozorowski · Scripps Institution of Oceanography8 papers (2015–2021)Jean‐Philippe Julien · University of Toronto8 papers (2013–2017) · 7 papers (2013–2021)Thomas J. Ketas · Cornell University6 papers (2013–2021)Jeong Hyun Lee · Scripps Institution of Oceanography6 papers (2013–2017)Rajesh P. Ringe · Institute of Microbial Technology5 papers (2013–2017)Max Crispin · Duke Medical Center5 papers (2015–2021)Christopher A. Cottrell · Scripps Research Institute5 papers (2015–2021)Dennis R. Burton · Scripps Research Institute5 papers (2014–2017)Steven W. de Taeye · Amsterdam University Medical Centers4 papers (2015–2021)Jacob Korzun · University of Pennsylvania4 papers (2013–2015) · 3 papers (2013–2015)Aleksandar Antanasijevic · University of Illinois Chicago3 papers (2020–2021) · 3 papers (2013–2015)